In order to reveal the molecular changes behind the effects of behavioral therapies on IBS symptoms, we investigated the effects of rodent behavioral interventions on different components that are critical to the development of visceral and somatic hypersensitivity: GR expression in the CeA (and hippocampus) and colonic permeability. Here, NR3C1 is linked to irritable bowel syndrome.